Serveur d'exploration sur l'Indium - Analysis (France)

Index « Auteurs » - entrée « J F Chatal »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

List of bibliographic references

Number of relevant bibliographic references: 24

.
Ident.Authors (with country if any)Title
000160 (1999) F Kraeber-Bodéré (France) ; A Faivre-Chauvet ; C Saï-Maurel ; L Campion ; M Fiche ; E Gautherot ; J Le Boterff ; J Barbet ; J F Chatal ; P ThédrezToxicity and efficacy of radioimmunotherapy in carcinoembryonic antigen-producing medullary thyroid cancer xenograft: comparison of iodine 131-labeled F(ab')2 and pretargeted bivalent hapten and evaluation of repeated injections.
000166 (1999) E Gautherot (France) ; F Kraeber-Bodéré ; L Daniel ; M Fiche ; E Rouvier ; C Saï-Maurel ; P Thedrez ; J F Chatal ; J BarbetImmunohistology of carcinoembryonic antigen (CEA)-expressing tumors grafted in nude mice after radioimmunotherapy with 131I-labeled bivalent hapten and anti-CEA x antihapten bispecific antibody.
000176 (1998) J Barbet (France) ; P Peltier ; S Bardet ; J P Vuillez ; I Bachelot ; S Denet ; P Olivier ; F Leccia ; B Corcuff ; D Huglo ; C Proye ; E Rouvier ; P Meyer ; J F ChatalRadioimmunodetection of medullary thyroid carcinoma using indium-111 bivalent hapten and anti-CEA x anti-DTPA-indium bispecific antibody.
000198 (1996) A Faivre-Chauvet (France) ; R C Mease ; A Chetanneau ; M Bardiès ; C Sai-Maurel ; G E Meinken ; S C Srivastava ; J F Chatal ; J F GestinPre-clinical and clinical studies of two new bifunctional chelating agents for immunoscintigraphy with 111In-anti-CEA monoclonal antibody.
000208 (1996) A Devys (France) ; P Thedrez ; E Gautherot ; A Faivre-Chauvet ; C Saï-Maurel ; E Rouvier ; J L Auget ; J Barbet ; J F ChatalComparative targeting of human colon-carcinoma multicell spheroids using one- and two-step (bispecific antibody) techniques.
000222 (1995) J F Chatal (France) ; A Faivre-Chauvet ; M Bardies ; P Peltier ; E Gautherot ; J BarbetBifunctional antibodies for radioimmunotherapy.
000237 (1993) P Peltier (France) ; J P Dutin ; J F Chatal ; P Fumoleau ; P Bourguet ; J C Liehn ; J P Vuillez ; J Y Hérry ; A LoboguerreroUsefulness of imaging ovarian cancer recurrence with In-111-labeled monoclonal antibody (OC 125) specific for CA 125 antigen. The INSERM Research Network (Nantes, Rennes, Reims, Vuillejuif, Saclay.
000241 (1993) P Peltier (France) ; C Curtet ; J F Chatal ; J M Le Doussal ; G Daniel ; G Aillet ; A Gruaz-Guyon ; J Barbet ; M DelaageRadioimmunodetection of medullary thyroid cancer using a bispecific anti-CEA/anti-indium-DTPA antibody and an indium-111-labeled DTPA dimer.
000244 (1993) A Faivre-Chauvet (France) ; J F Gestin ; R C Mease ; C Sai-Maurel ; P Thédrez ; M Slinkin ; G E Meinken ; S C Srivastava ; J F ChatalIntroduction of five potentially metabolizable linking groups between 111In-cyclohexyl EDTA derivatives and F(ab')2 fragments of anti-carcinoembryonic antigen antibody--II. Comparative pharmacokinetics and biodistribution in human colorectal carcinoma-bearing nude mice.
000245 (1993) J F Gestin (France) ; A Faivre-Chauvet ; R C Mease ; C Sai-Maurel ; P Thédrez ; M Slinkin ; G E Meinken ; S C Srivastava ; J F ChatalIntroduction of five potentially metabolizable linking groups between 111In-cyclohexyl EDTA derivatives and F(ab')2 fragments of anti-carcinoembryonic antigen antibody--I. A new reproducible synthetic method.
000248 (1993) J M Le Doussal (France) ; A Chetanneau ; A Gruaz-Guyon ; M Martin ; E Gautherot ; P A Lehur ; J F Chatal ; M Delaage ; J BarbetBispecific monoclonal antibody-mediated targeting of an indium-111-labeled DTPA dimer to primary colorectal tumors: pharmacokinetics, biodistribution, scintigraphy and immune response.
000249 (1993) M A Slinkin (France) ; C Curtet ; A Faivre-Chauvet ; C Sai-Maurel ; J F Gestin ; V P Torchilin ; J F ChatalBiodistribution of anti-CEA F(ab')2 fragments conjugated with chelating polymers: influence of conjugate electron charge on tumor uptake and blood clearance.
000254 (1992) M Bardiès (France) ; P Thedrez ; J F Gestin ; B M Marcille ; D Guerreau ; A Faivre-Chauvet ; M Mahé ; C Sai-Maurel ; J F ChatalUse of multi-cell spheroids of ovarian carcinoma as an intraperitoneal radio-immunotherapy model: uptake, retention kinetics and dosimetric evaluation.
000258 (1992) J P Vuillez (France) ; P Peltier ; J P Caravel ; A Chetanneau ; J C Saccavini ; J F ChatalImmunoscintigraphy using 111In-labeled F(ab')2 fragments of anticarcinoembryonic antigen monoclonal antibody for detecting recurrences of medullary thyroid carcinoma.
000259 (1992) P Peltier (France) ; K Wiharto ; J P Dutin ; J F Chatal ; P Bourguet ; J C Liehn ; J P Vuillez ; J Y Hérry ; A LoboguerreroCorrelative imaging study in the diagnosis of ovarian cancer recurrences. The INSERM Research Network (Nantes, Rennes, Reims, Villejuif, Saclay), France.
000266 (1991) J P Vuillez (France) ; P Peltier ; J C Mayer ; F Dubois ; A Chetanneau ; P Fumoleau ; A Bertrand ; J F ChatalReproducibility of image interpretation in immunoscintigraphy performed with indium-111- and iodine-131-labeled OC125 F(ab')2 antibody injected into the same patients.
000271 (1991) P De Faucal (France) ; P Peltier ; B Planchon ; B Dupas ; M D Touze ; D Baron ; T Scaible ; H J Berger ; J F ChatalEvaluation of indium-111-labeled antifibrin monoclonal antibody for the diagnosis of venous thrombotic disease.
000279 (1990) A Chetanneau (France) ; R P Baum ; P A Lehur ; J C Liehn ; A C Perkins ; R Bares ; P Bourguet ; J Y Herry ; J C Saccavini ; J F ChatalMulti-centre immunoscintigraphic study using indium-111-labelled CEA-specific and/or 19-9 monoclonal antibody F(ab')2 fragments.
000283 (1990) C Curtet (France) ; J P Vuillez ; G Daniel ; G Aillet ; A Chetanneau ; J Visset ; M Kremer ; P Thédrez ; J F ChatalFeasibility study of radioimmunoguided surgery of colorectal carcinomas using indium-111 CEA-specific monoclonal antibody.
000289 (1989) A Chetanneau (France) ; P A Lehur ; D Ripoche ; P Peltier ; J C Saccavini ; J P Vuillez ; N Tournemaine ; P Thedrez ; J F ChatalHistological correlation of 17 prospective immunoscintigraphies of recurrences of colorectal carcinomas using indium-111-labeled anti-cea and(or) 19-9 monoclonal antibodies.
000292 (1989) J F Chatal (France) ; J C Saccavini ; J F Gestin ; P Thédrez ; C Curtet ; M Kremer ; D Guerreau ; D Nolibé ; P Fumoleau ; Y GuillardBiodistribution of indium-111-labeled OC 125 monoclonal antibody intraperitoneally injected into patients operated on for ovarian carcinomas.
000293 (1989) P Thédrez (France) ; J C Saccavini ; D Nolibé ; J P Simoen ; D Guerreau ; J F Gestin ; M Kremer ; J F ChatalBiodistribution of indium-111-labeled OC 125 monoclonal antibody after intraperitoneal injection in nude mice intraperitoneally grafted with ovarian carcinoma.
000309 (????) L Morandeau (France) ; E Benoist ; A Loussouarn ; A Ouadi ; P Lesaec ; M Mougin ; A Faivre-Chauvet ; J Le Boterff ; J F Chatal ; J Barbet ; J F GestinSynthesis of new bivalent peptides for applications in the Affinity Enhancement System.
000316 (????) A Hamy (France) ; C Curtet ; J Paineau ; J F Chatal ; J VissetFeasibility of radioimmunoguided surgery of colorectal carcinoma using indium 111 CEA specific antibody and simulation with a phantom using 2 steps targetting with bispecific antibody.

List of associated KwdEn.i

Nombre de
documents
Descripteur
21Humans
17Indium Radioisotopes (diagnostic use)
16Female
13Carcinoembryonic Antigen (immunology)
10Middle Aged
9Male
8Animals
7Aged
7Colorectal Neoplasms (radionuclide imaging)
7Mice
6Adenocarcinoma (radionuclide imaging)
6Adult
6Antibodies, Monoclonal (diagnostic use)
6Mice, Nude
5Neoplasm Recurrence, Local (radionuclide imaging)
4Indium Radioisotopes (pharmacokinetics)
4Neoplasm Transplantation
4Radioimmunodetection (methods)
4Sensitivity and Specificity
4Tissue Distribution
4Tumor Cells, Cultured
3Aged, 80 and over
3Antibodies, Bispecific (therapeutic use)
3Antibodies, Monoclonal (metabolism)
3Antigens, Tumor-Associated, Carbohydrate (immunology)
3Edetic Acid (analogs & derivatives)
3Immunoglobulin Fab Fragments (immunology)
3Immunoglobulin Fragments (metabolism)
3Radioimmunodetection
3Radioimmunotherapy
3Thyroid Neoplasms (radionuclide imaging)
3Transplantation, Heterologous
2Adenocarcinoma (metabolism)
2Antibodies, Bispecific (diagnostic use)
2Antibodies, Bispecific (pharmacokinetics)
2Antibodies, Monoclonal (administration & dosage)
2Antibodies, Monoclonal (immunology)
2Antibody Specificity
2Antigens, Neoplasm (immunology)
2Carcinoembryonic Antigen (analysis)
2Carcinoembryonic Antigen (metabolism)
2Carcinoma (radionuclide imaging)
2Chelating Agents
2Chelating Agents (metabolism)
2Colonic Neoplasms (metabolism)
2Colonic Neoplasms (radiotherapy)
2Colorectal Neoplasms (immunology)
2Colorectal Neoplasms (surgery)
2Feasibility Studies
2Haptens (therapeutic use)
2Immunoglobulin Fab Fragments
2Immunoglobulin Fragments (chemistry)
2Injections, Intraperitoneal
2Iodine Radioisotopes (therapeutic use)
2Models, Structural
2Ovarian Neoplasms (metabolism)
2Ovarian Neoplasms (radionuclide imaging)
2Ovarian Neoplasms (surgery)
2Pentetic Acid (diagnostic use)
2Radioimmunotherapy (methods)
2Reproducibility of Results
2Thyroid Neoplasms (pathology)
2Thyroid Neoplasms (radiotherapy)
2Time Factors
2Tomography, Emission-Computed
2Tomography, X-Ray Computed
1Adenocarcinoma (blood)
1Adenocarcinoma (diagnosis)
1Adenocarcinoma (epidemiology)
1Adenocarcinoma (immunology)
1Adenocarcinoma (secondary)
1Adenocarcinoma (surgery)
1Antibodies (metabolism)
1Antibodies, Anti-Idiotypic (analysis)
1Antibodies, Anti-Idiotypic (metabolism)
1Antibodies, Bispecific (chemistry)
1Antibodies, Bispecific (immunology)
1Antibodies, Bispecific (isolation & purification)
1Antibodies, Monoclonal
1Antibodies, Monoclonal (chemistry)
1Antibodies, Monoclonal (isolation & purification)
1Antibodies, Monoclonal (pharmacokinetics)
1Antigens, Tumor-Associated, Carbohydrate
1Antigens, Tumor-Associated, Carbohydrate (blood)
1Benzylamines (chemistry)
1Binding Sites
1Biological Transport
1Carcinoma (metabolism)
1Carcinoma (surgery)
1Carcinoma (therapy)
1Carcinoma, Medullary (pathology)
1Carcinoma, Medullary (radionuclide imaging)
1Carcinoma, Medullary (radiotherapy)
1Carcinoma, Medullary (secondary)
1Carcinoma, Medullary (surgery)
1Chelating Agents (chemical synthesis)
1Chelating Agents (chemistry)
1Chelating Agents (pharmacokinetics)
1Chemistry, Physical
1Chromatography, High Pressure Liquid

Affichage en shell (Unix/Dilib)

IndexSelect -h IndiumV2/Data/France/Analysis/Author.i -k "J F Chatal" 
IndexSelect -h IndiumV2/Data/France/Analysis/Author.i  \
                -Sk "J F Chatal" \
         | HfdSelect -Kh IndiumV2/Data/France/Analysis/biblio.hfd 

Wicri

This area was generated with Dilib version V0.5.76.
Data generation: Tue May 20 07:24:43 2014. Site generation: Tue May 20 08:20:52 2014